A citation-based method for searching scientific literature

Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
Times Cited: 266



Elisabeth M Kingma, Erik van Duijn, Reinier Timman, Rose C van der Mast, Raymund A C Roos. Gen Hosp Psychiatry 2008
Times Cited: 99




List of shared articles



Times cited

Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis.
Megha Ranganathan, Sandra K Kostyk, Dawn C Allain, Jonathan A Race, Allison M Daley. Clin Genet 2021
1

Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease.
Audrey E De Paepe, Alberto Ara, Clara Garcia-Gorro, Saül Martinez-Horta, Jesus Perez-Perez, Jaime Kulisevsky, Nadia Rodriguez-Dechicha, Irene Vaquer, Susana Subira, Matilde Calopa,[...]. Mov Disord 2021
0

Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study.
Simone Migliore, Giulia D'Aurizio, Sabrina Maffi, Consuelo Ceccarelli, Giovanni Ristori, Silvia Romano, Anna Castaldo, Caterina Mariotti, Giuseppe Curcio, Ferdinando Squitieri. Brain Behav 2021
4

A Systematic Review of Neuropsychiatric Symptoms and Functional Capacity in Huntington's Disease.
Jessie Sellers, Sheila H Ridner, Daniel O Claassen. J Neuropsychiatry Clin Neurosci 2020
7

Gene Expression Profiling in Huntington's Disease: Does Comorbidity with Depressive Symptoms Matter?
Gabriela Delevati Colpo, Natalia Pessoa Rocha, Erin Furr Stimming, Antonio Lucio Teixeira. Int J Mol Sci 2020
1

Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB1R Levels.
Jenny Ceccarini, Rawaha Ahmad, Laura Van de Vliet, Cindy Casteels, Mathieu Vandenbulcke, Wim Vandenberghe, Koen Van Laere. J Nucl Med 2019
10

Validity of irritability in Huntington's disease: A scoping review.
Jane Simpson, Maria Dale, Rachael Theed, Sarah Gunn, Nicolò Zarotti, Fiona J R Eccles. Cortex 2019
8

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease.
Audrey E De Paepe, Joanna Sierpowska, Clara Garcia-Gorro, Saül Martinez-Horta, Jesus Perez-Perez, Jaime Kulisevsky, Nadia Rodriguez-Dechicha, Irene Vaquer, Susana Subira, Matilde Calopa,[...]. Neuroimage Clin 2019
16

The psychopharmacology of Huntington disease.
Åsa Petersén, Patrick Weydt. Handb Clin Neurol 2019
6


Spanish Validation of the Problem Behaviors Assessment-Short (PBA-s) for Huntington's Disease.
Jesús M Ruiz-Idiago, Misericordia Floriach, Cèlia Mareca, Raymond Salvador, José Luis López-Sendón, Verónica Mañanés, Esther Cubo, Natividad Mariscal, Esteban Muñoz, Pilar Santacruz,[...]. J Neuropsychiatry Clin Neurosci 2017
3

Neuroimaging as a tool to study the sources of phenotypic heterogeneity in Huntington's disease.
Clara Garcia-Gorro, Estela Camara, Ruth de Diego-Balaguer. Curr Opin Neurol 2017
2

Huntington's Disease: Premotor Phase.
Ana Rita Saldanha Ramos, Carolina Garrett. Neurodegener Dis 2017
6

Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.
Eric A Epping, Ji-In Kim, David Craufurd, Thomas M Brashers-Krug, Karen E Anderson, Elizabeth McCusker, Jolene Luther, Jeffrey D Long, Jane S Paulsen. Am J Psychiatry 2016
62

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, Ramon Fernandez-Bobadilla, Mar Carceller, Javier Pagonabarraga, Berta Pascual-Sedano, Antonia Campolongo, Jesus Ruiz-Idiago, Frederic Sampedro,[...]. Parkinsonism Relat Disord 2016
80

Neurochemical correlation between major depressive disorder and neurodegenerative diseases.
Gislaine Z Réus, Stephanie E Titus, Helena M Abelaira, Sharon M Freitas, Talita Tuon, João Quevedo, Josiane Budni. Life Sci 2016
20

Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
Joana Duarte-Neves, Luís Pereira de Almeida, Cláudia Cavadas. Neurobiol Dis 2016
62